These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 12090543

  • 1. Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases.
    Bornhövd EC, Burgdorf WH, Wollenberg A.
    Curr Opin Investig Drugs; 2002 May; 3(5):708-12. PubMed ID: 12090543
    [Abstract] [Full Text] [Related]

  • 2. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
    Bornhövd E, Burgdorf WH, Wollenberg A.
    J Am Acad Dermatol; 2001 Nov; 45(5):736-43. PubMed ID: 11606925
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Potential new indications of topical calcineurin inhibitors.
    Luger T, Paul C.
    Dermatology; 2007 Nov; 215 Suppl 1():45-54. PubMed ID: 18174692
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pimecrolimus 1% cream (Elidel) for atopic dermatitis.
    Bernard LA, Bergman JN, Eichenfield LF.
    Skin Therapy Lett; 2002 Apr; 7(4):1-3. PubMed ID: 12097994
    [Abstract] [Full Text] [Related]

  • 9. Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus.
    Stuetz A, Baumann K, Grassberger M, Wolff K, Meingassner JG.
    Int Arch Allergy Immunol; 2006 Apr; 141(3):199-212. PubMed ID: 16926539
    [Abstract] [Full Text] [Related]

  • 10. Topical pimecrolimus for skin disease other than atopic dermatitis.
    Wollina U, Hansel G, Koch A, Abdel-Naser MB.
    Expert Opin Pharmacother; 2006 Oct; 7(14):1967-75. PubMed ID: 17020422
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pimecrolimus--a safe and effective local immunomodulator in the treatment of inflammatory skin diseases.
    Lipozencić J.
    Acta Dermatovenerol Croat; 2005 Oct; 13(1):63-9. PubMed ID: 15788149
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
    Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
    [Abstract] [Full Text] [Related]

  • 15. Pimecrolimus: a review.
    Gupta AK, Chow M.
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):493-503. PubMed ID: 12941081
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF, Calvieri S, Ortonne JP, Ho VC, Weise-Riccardi S, Barbier N, Paul CF.
    Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
    [Abstract] [Full Text] [Related]

  • 18. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA.
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [Abstract] [Full Text] [Related]

  • 19. Pimecrolimus -- an anti-inflammatory drug targeting the skin.
    Grassberger M, Steinhoff M, Schneider D, Luger TA.
    Exp Dermatol; 2004 Dec; 13(12):721-30. PubMed ID: 15560755
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.